Oxford Nanopore appoints John O’Higgins to Board
Fri 10th January 2020
Oxford Nanopore is delighted to announce the appointment of John O’Higgins to its Board, as a Non-Executive Director.
John was previously CEO of Spectris, the international productivity-enhancing instrumentation and controls company, where he led rapid global growth and evolution of the company as it pursued multiple market applications from a broad technology platform.
John holds several non-executive roles including at the global science and chemicals company Johnson Matthey plc, whose solutions are designed to enable cleaner air, improved health and the more efficient use of natural resources. He also served as a non-executive Director of Exide Technologies, the US-based supplier of battery technology to automotive and industrial users.
John is also a Member of the Corporate Advisory Board of Great Ormond Street Hospital Charity in the UK.
“The Directors are delighted to welcome John O’Higgins to our Board,” said Peter Allen, Chair of Oxford Nanopore. “John has extensive experience in science and technology companies that can address, or enable broad markets. His experience working with rapidly growing companies is also hugely valuable to Oxford Nanopore as we transition from an emerging company into one with more mature products and operations.”
John O’Higgins added “I am very excited to supporting the Company in its mission to enable the analysis of any living thing, by anyone, anywhere. The trajectory of technology development in recent years at Oxford Nanopore has been remarkable, and I am proud to join a company in the foothills of huge commercial disruption.”
Clive Brown, CTO of Oxford Nanopore, has also joined the Board.